The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
Abstract
Specific brain sites for the opiate abstinence syndrome syndrome have been elusive to delineate, and the classic overt signs of withdrawal such as wet dog shakes, ptosis and teeth chattering appear to be widely represented in the brain. Using a more general motivational test involving a disruption of operant behavior in dependent rats, the brain site most sensitive to the response disruptive effects of intracerebral administration of the opiate antagonist, methylnaloxonium, was the region of the nucleus accumbens, a site also implicated in the acute reinforcing properties of opiates. This disruption of operant responding was hypothesized to reflect the aversive properties of opiate withdrawal. The present study directly tested that hypothesis by exploring whether intercerebral administration of methylnaloxonium produced aversive stimulus effects as measured by the formation of place aversions. Rats implanted intracerebroventricularly or with bilateral cannulae aimed at the medial dorsal thalamus, periaqueductal gray, ventral tegmental area, amygdala or nucleus accumbens were made dependent on morphine by subcutaneous implantation of two 75-mg morphine pellets. The animals were then subjected to place aversion training by pairing of a distinct environment (one of three arms of a three-armed box with distinct texture, markings and smell) with a single injection of methylnaloxonium intracerebroventricularly or intracerebrally. Results showed that at high doses of methylnaloxonium (1000-2000 ng) all sites produced a place aversion. However, lower doses (250-500 ng) produced a significant brain site selectivity with the region of the nucleus accumbens the most sensitive. Observational measurements taken during the postinjection period with the high dose of methylnaloxonium showed that agitation was particularly observed following methylnaloxonium administration into the nucleus accumbens and periaqueductal gray.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other observed changes include increases in μ opioid receptor responsivity during opioid withdrawal,71,72 and decreases in GABAergic and increases in NMDA glutamatergic transmission in the nucleus accumbens.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [71]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Nonparametric Statistics for the Behavioral Sciences.
Whitfield, J. W., & Siegel, S. (1957) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2342828 · Cited by 7,947
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
A stereotaxic atlas of the rat brain
Brodal, P. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90013-5 · Cited by 2,782
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citation[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Fraunfelder, F. T. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90318-4 · Cited by 1,331
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Drug dependence: its significance and characteristics.
Eddy, N. O., Halbach, H., Isbell, H., & Seevers, M. H. (1965) · Europe PMC (PubMed Central) · Cited by 297
Research works printed but not linked: 1
- Adler, 1978, Inability of acute or chronic thalamic, limbic, or cortical lesions to alter narcotic dependence and abstinence in rats, Devl Neurosci., 4, 51
Cited by
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
Self-citationDrug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationThe amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Self-citationReward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Self-citationThe neurobiology of drug addiction
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.482 · Cited by 562
Self-citationBiological substrates of reward and aversion: A nucleus accumbens activity hypothesis
Carlezon, W. A., & Thomas, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.075 · Cited by 561
Evidence That Intermittent, Excessive Sugar Intake Causes Endogenous Opioid Dependence
Colantuoni, C., Rada, P., McCarthy, J., Patten, C., Avena, N. M., Chadeayne, A., & Hoebel, B. G. (2002) · Obesity Research · doi:10.1038/oby.2002.66 · Cited by 545
The changing opioid crisis: development, challenges and opportunities
Volkow, N. D., & Blanco, C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0661-4 · Cited by 522
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“Such place aversions, when used to measure the aversive stimulus effects of withdrawal, have been observed largely in the context of opioids (Hand et al., 1988; Stinus et al., 1990).”
BackgroundSelf-citationRole of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Self-citationNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 458
Self-citationThe dark side of emotion: the addiction perspective
Koob, G. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.044 · Cited by 433
“However, there are also drugspecific changes, such as increased sensitivity of opioid receptor transduction mechanisms in the nucleus accumbens during opioid withdrawal (Stinus et al., 1990), decreased g-aminobutyric acid (GABA)-ergic and increased NMDA glutamatergic transmission G.”
BackgroundSelf-citationThe neurobiology of addiction: a neuroadaptational view relevant for diagnosis
Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397
“Examples of such changes at the neurochemical level include decreases in dopaminergic and serotonergic transmission in the nucleus accumbens during drug withdrawal as measured by in vivo microdialysis [13,14], increased sensitivity of opioid receptor transduction mechanisms in the nucleus accumbens during opiate withd…”
BackgroundSelf-citationAddiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Self-citationBrain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388
“Precipitated withdrawal from opioids also produces place aversions (Stinus et al., 1990).”
BackgroundSelf-citationThe Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 359
Self-citationAnimal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
Self-citationThe Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09282.x · Cited by 321
Self-citationNeurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317
Self-citationGeorge, O., & Koob, G. F. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.05.002 · Cited by 313
Self-citationNeurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 303
Relapse to drug-seeking: neural and molecular mechanisms
Self, D. W., & Nestler, E. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00065-9 · Cited by 295
Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288
The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
Melis, M., Spiga, S., & Diana, M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63005-x · Cited by 273
Neural Systems Underlying Opiate Addiction
De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
Ghozland, S., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263
ASTON‐JONES, G., DELFS, J. M., DRUHAN, J., & ZHU, Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09284.x · Cited by 250
Cannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 250
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237
Stress, Corticotropin‐releasing Factor, and Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07876.x · Cited by 231
Self-citationLeshner, A. I., & Koob, G. F. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09218.x · Cited by 217
Self-citationWatkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214
“Distinctive visual and tactile cues distinguished the three compartments (Stinus et al., 1990).”
BackgroundSelf-citationInvolvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Frenois, F., Cador, M., Caillé, S., Stinus, L., & Le Moine, C. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02187.x · Cited by 179
Self-citationAccumbens dopamine-acetylcholine balance in approach and avoidance
Hoebel, B. G., Avena, N. M., & Rada, P. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.014 · Cited by 177
How expectations influence pain
Fields, H. L. (2018) · Pain · doi:10.1097/j.pain.0000000000001272 · Cited by 175
“Furthermore, in opioid-dependent rats, opioid antagonists microinjected into the NAc and VTA produce an aversive output.(51) These studies raise the possibility that parallel circuits in these regions can mediate aversion and”
BackgroundWalters, C. L., & Blendy, J. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09438.2001 · Cited by 175
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
“Recruitment of brain stress systems in addiction Corticotropin-releasing factor A common response to acute withdrawal and protracted abstinence from all major drugs of abuse in humans is the manifestation of a nxiety-like or aversive-like states, and animal models have revealed anxiety-like or aversivelike responses t…”
BackgroundSelf-citationSharf, R., Sarhan, M., & Dileone, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.006 · Cited by 155
Rada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141
Central Administration of an Opiate Antagonist Decreases Oral Ethanol Self-Administration in Rats
Heyser, C. J., Roberts, A. J., Schulteis, G., & Koob, G. F. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04669.x · Cited by 149
Self-citationStinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139
Self-citationIndividual differences in the neuropsychopathology of addiction
George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 166
Self-citationRole of oxytocin in the neuroadaptation to drugs of abuse
Sarnyai, Z., & Kovács, G. L. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90062-0 · Cited by 148
Gold, L. H., Stinus, L., Inturrisi, C. E., & Koob, G. F. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90755-2 · Cited by 142
Self-citationChartoff, E. H., & Connery, H. S. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00116 · Cited by 154
μ-Opioid Receptors Modulate NMDA Receptor-Mediated Responses in Nucleus Accumbens Neurons
Martin, G. E., Nie, Z., & Siggins, G. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00011.1997 · Cited by 157
Neuropharmacology of Cocaine and Ethanol Dependence
Koob, G. F., & Weiss, F. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_11 · Cited by 138
Self-citationStornetta, R. L., Norton, F. E., & Guyenet, P. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)90055-r · Cited by 134
Gracy, K. N., Dankiewicz, L. A., & Koob, G. F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00186-x · Cited by 135
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist
Popik, P., & Wróbel, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00309-x · Cited by 131
Rasmussen, K., Kendrick, W. T., Kogan, J. H., & Aghajanian, G. K. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00094-2 · Cited by 117
A Specific Limbic Circuit Underlies Opiate Withdrawal Memories
Frenois, F., Stinus, L., Blasi, F. D., Cador, M., & Moine, C. L. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3090-04.2005 · Cited by 129
Self-citationCarlezon, W. A., & Konradi, C. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.021 · Cited by 118
Spanagel, R., Almeida, O. F. X., Bartl, C., & Shippenberg, T. S. (1994) · Psychopharmacology · doi:10.1007/bf02244761 · Cited by 119
Dahchour, A., Quertemont, É., & Witte, P. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00537-9 · Cited by 109
Reinforcement processes in opiate addiction: A homeostatic model
Schulteis, G., & Koob, G. F. (1996) · Neurochemical Research · doi:10.1007/bf02532385 · Cited by 121
Self-citationInhibition of PKMζ in Nucleus Accumbens Core Abolishes Long-Term Drug Reward Memory
Li, Y.-Q., Xue, Y.-X., He, Y., Li, F., Xue, L., Xu, C., Sacktor, T. C., Shaham, Y., & Lü, L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5884-10.2011 · Cited by 115
Hildebrand, B. E., Panagis, G., Svensson, T. H., & Nomikos, G. G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 110
Rasmussen, K. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00082-o · Cited by 104
Self, D. W., Terwilliger, R. Z., Nestler, E. J., & Stein, L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06239.1994 · Cited by 103
Schneider, T., Ziółkowska, B., Gieryk, A., Tyminska, A., & Przewłocki, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0795-y · Cited by 101
Schulteis, G., Yackey, M., Risbrough, V., & Koob, G. F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00034-3 · Cited by 97
Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.399 · Cited by 91
Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal
Azar, M. R., Jones, B. C., & Schulteis, G. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1514-y · Cited by 91
Opponent process and drug dependence: Neurobiological mechanisms
Koob, G. F., Markou, A., Weiss, F., & Schulteis, G. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80043-0 · Cited by 96
Self-citationOpiate withdrawal-induced place aversion lasts for up to 16 weeks
Stinus, L., Caillé, S., & Koob, G. F. (2000) · Psychopharmacology · doi:10.1007/s002139900358 · Cited by 101
Self-citationMatsuoka, I., Maldonado, R. J., Defer, N., Noël, F., Hanoune, J., & Roques, B. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90191-0 · Cited by 89
Drug addiction: Functional neurotoxicity of the brain reward systems
Weiss, F., & Koob, G. F. (2001) · Neurotoxicity Research · doi:10.1007/bf03033235 · Cited by 96
Self-citationA Two-Separate-Motivational-Systems Hypothesis of Opioid Addiction
Bechara, A., Nader, K., & van der Kooy, D. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00047-6 · Cited by 98
Nylander, I., Vlaskovska, M. V., & Terenius, L. Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00279-y · Cited by 93
Caillé, S., Fernández‐Espejo, E., Rénéric, J.-P., Cador, M., Koob, G. F., & Stinus, L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34977-8 · Cited by 87
Self-citationZarrindast, M., Babapoor-Farrokhran, S., Babapoor-Farrokhran, S., & Rezayof, A. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.03.020 · Cited by 91
Naloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice
Skoubis, P. D., Matthes, H. W. D., Walwyn, W. M., Kieffer, B. L., & Maidment, N. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00333-5 · Cited by 86
Chartoff, E. H., Mague, S. D., Barhight, M. F., Smith, A. M., & Carlezon, W. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0491-06.2006 · Cited by 91
Higgins, G. A., & Sellers, E. M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90489-8 · Cited by 88
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro
Hack, S. P., Vaughan, C. W., & Christie, M. J. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00205-3 · Cited by 88
Rada, P., Mark, G. P., Taylor, K. M., & Hoebel, B. G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02078-0 · Cited by 85
Noble, F., & Cox, B. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15169.x · Cited by 86
Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice
Skoubis, P. D., Lam, H. A., Shoblock, J. R., Narayanan, S., & Maidment, N. T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03956.x · Cited by 84
Higgins, G. A., Nguyen, P., & Sellers, E. M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90452-u · Cited by 81
Dark Times: The Role of Negative Reinforcement in Methamphetamine Addiction
May, A. C., Aupperle, R. L., & Stewart, J. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00114 · Cited by 89
Sepúlveda, M., Hernandez, L. F., Rada, P. V., Tucci, S. A., & Contreras, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00550-9 · Cited by 83
Koob, G. F. (2011) · Focus · doi:10.1176/foc.9.1.foc55 · Cited by 79
Self-citationRada, P. V., Pothos, E. N., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91616-9 · Cited by 78
Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence
LIU, J., & Schulteis, G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.06.006 · Cited by 78
Walker, J. R., Ahmed, S. H., Gracy, K. N., & Koob, G. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02288-x · Cited by 75
Self-citationBagley, E. E., Gerke, M. B., Vaughan, C. W., Hack, S. P., & Christie, M. J. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.049 · Cited by 79
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74
Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
Cador, M., Ahmed, S. H., Koob, G. F., Le Moal, M., & Stinus, L. (1992) · Brain Research · doi:10.1016/0006-8993(92)91487-y · Cited by 74
Self-citationPantazis, C. B., Gonzalez, L. A., Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2021) · Science Advances · doi:10.1126/sciadv.abf0364 · Cited by 77
Self-citationNegus, S. S., & Rice, K. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.127 · Cited by 70
“…and motivational signs of opioid withdrawal, such as conditioned place aversions and reductions in rates of foodmaintained responding, appear to be mediated by reductions in midbrain dopamine release in regions such as nucleus accumbens (Stinus et al, 1990; Acquas et al, 1991; Criner et al, 2007).”
Metadata
- Authors
- Stinus, L., Le Moal, M., & Koob, G. F.
- Affiliations
- Inserm (FR)
- Scripps Research Institute (US)
- Corresponding author
- Koob, G.F.
- ORCID
- Koob, G.F.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1990-01
- Volume
- 37
- Issue
- 3
- Pages
- 767-773
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2043787639
- Cited by
- 317
- References
- 23
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 6
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (NIDA04043, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- opioid withdrawal, nucleus accumbens, amygdala, place aversion, morphine dependence, periaqueductal gray, mediodorsal thalamus, ventral tegmental area, intracerebral administration, agitation
- MeSH terms
- Quaternary Ammonium Compounds, Amygdala, Animals, Conditioning, Operant, Injections, Intraventricular, Male, Morphine Dependence, Naloxone, Nucleus Accumbens, Rats, Inbred Strains, Substance Withdrawal Syndrome, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.